Join the club for FREE to access the whole archive and other member benefits.

Stem cells, lab-grown meat, and potential new medical treatments, with Mark Kotter

Mark Kotter discusses stem cells, cultivated meat, and emerging medical treatments

Dr. Mark Kotter is the founder or co-founder of three biotech startups—bit.bio, clock.bio, and Meatable—which have collectively raised hundreds of millions of pounds. He continues to perform weekly neurosurgeries at the University of Cambridge. This episode highlights his work, starting with Meatable, a leading company in the cultured meat sector with transformative potential.

Key Points:

The podcast explores the innovative work of Dr. Mark Kotter, neurosurgeon, stem cell biologist, and biotech entrepreneur. His ventures tackle critical challenges in regenerative medicine and sustainable food production.

  • Journey into Medicine and Innovation: Dr. Kotter began with a mathematics background but pivoted to medicine and stem cell biology, inspired by practical impacts and patient care. His experiences in spinal injury shaped his career in neurosurgery and regenerative medicine.
  • Revolutionizing Stem Cell Technology: He critiques the inefficiencies of traditional stem cell paradigms, highlighting how synthetic biology now offers faster, more scalable, and consistent methods for creating therapeutic cells.
  • Cultured Meat with Meatable: Dr. Kotter's company Meatable employs advanced stem cell techniques to produce lab-grown pork. These products mimic real meat, addressing ethical concerns, reducing greenhouse gas emissions, and avoiding reliance on animal-derived materials.
  • Economic Feasibility of Cultured Meat: Meatable is nearing cost parity with farmed meat, driven by scaling innovations. Dr. Kotter envisions broad adoption within two years, with younger, environmentally conscious consumers leading demand.
  • Future of Regenerative Medicine: His startup bit.bio focuses on scalable, consistent production of human cells for therapeutic uses, targeting diseases like Parkinson's, diabetes, and liver failure. Advances promise transformative impacts on healthcare.
  • Broader Implications for Sustainability: The transition to cultured meat could reclaim vast agricultural lands, offering opportunities for rewilding and reducing the dominance of livestock in global biomass.










Visit website: https://londonfuturists.buzzsprout.com/2028982/episodes/15139340-stem-cells-lab-grown-meat-and-potential-new-medical-treatments-with-mark-kotter

See also: Publisher London Futurists-Podcast - London Futurists: Expert discussions on future trends

Details last updated 23-Nov-2024

Mentioned in this Resource

Bit.bio

Human cell coding company

clock.bio

Longevity biotech company

Mark Kotter

Neurosurgeon, stem cell biologist and founder of bit.bio

Meatable

Dutch biotechnology company aimed at cultured meat, particularly pork